Chemical Compound Produces Beneficial Inflammation and Remyelination That Could Help Treat Multiple Sclerosis
UC Riverside-led study shows that ‘good inflammation’ promotes axon myelination By Iqbal Pittalwala RIVERSIDE, Calif. (www.ucr.edu) — Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the body’s immune system to reduce disease symptoms and disability. They do not induce, however, repair of damaged axons,…



